Journey Medical Corp - Common Stock (DERM)

Q4 2021 13F Holders as of 12/31/2021

Type / Class: Equity / Common Stock
Shares outstanding: 17.2M
Number of holders: 14
Total 13F shares, excl. options: 1.63M
Shares change: +1.63M
Total reported value, excl. options: $8.76M
Value change: +$8.76M
Number of buys: 14
Price: $5.38

Significant Holders of Journey Medical Corp - Common Stock (DERM) as of Q4 2021

14 filings reported holding DERM - Journey Medical Corp - Common Stock as of Q4 2021.
Journey Medical Corp - Common Stock (DERM) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1.63M shares of 17.2M outstanding shares and own 9.46% of the company stock.
Largest 10 shareholders include B. Riley Financial, Inc. (865K shares), Neuberger Berman Group LLC (199K shares), AMERICAN FINANCIAL GROUP INC (180K shares), PERKINS CAPITAL MANAGEMENT INC (141K shares), Millrace Asset Group, Inc. (114K shares), CANNELL CAPITAL LLC (41.1K shares), GOLDMAN SACHS GROUP INC (35.8K shares), B. Riley Wealth Management, Inc. (15K shares), CITADEL ADVISORS LLC (10.8K shares), and Tudor Investment Corp Et Al (10.6K shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.